ArticleSignal transduction and targeted therapy2026

Dual-targeting pharmacological UFMylation inhibition reprograms tumor and immune microenvironments to achieve long-term glioblastoma regression.

Pengcheng Tan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.